Stephen Fawell Selected Research

Stephen Fawell Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 10/2006
4	Breast Neoplasms (Breast Cancer) 12/2020 - 02/2015
2	Melanoma (Melanoma, Malignant) 01/2016 - 07/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Disease Progression 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2018
1	Triple Negative Breast Neoplasms 10/2014
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2014
1	Prostatic Neoplasms (Prostate Cancer) 12/2012
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2010
1	Carcinogenesis 08/2010

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2014
2	Estrogen ReceptorsIBA 12/2020 - 08/2016
2	snake venom protein C activatorIBA 01/2020 - 11/2018
2	LigandsIBA 01/2020 - 08/2010
2	Proteolysis Targeting ChimeraIBA 01/2020 - 11/2018
2	Everolimus FDA Link 08/2016 - 02/2015
2	SCH772984IBA 01/2016 - 07/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 07/2013
2	AntibodiesIBA 08/2010 - 10/2006
1	Antisense OligonucleotidesIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	IndazolesIBA 12/2020
1	danvatirsenIBA 12/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	durvalumabIBA 01/2020
1	compound 21IBA 01/2020
1	AZD3229IBA 01/2020
1	regorafenibIBA 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Platelet-Derived Growth FactorIBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020
1	osimertinibIBA 01/2020
1	Drug CombinationsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	C-terminal binding proteinIBA 12/2018
1	Vorinostat FDA Link 08/2016
1	palbociclibIBA 08/2016
1	Fulvestrant (Faslodex)FDA Link 08/2016
1	Estrogens (Estrogen)FDA Link 02/2015
1	matrigelIBA 02/2015
1	Mitogen-Activated Protein KinasesIBA 07/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2012
1	TOR Serine-Threonine KinasesIBA 12/2012
1	TensinsIBA 12/2012
1	MTOR InhibitorsIBA 12/2012
1	PanobinostatIBA 11/2010
1	Therapeutic UsesIBA 08/2010
1	beta CateninIBA 08/2010
1	Wnt ProteinsIBA 08/2010
1	Lymphotoxin beta ReceptorIBA 10/2006
1	Monoclonal AntibodiesIBA 10/2006

Therapy/Procedure

7	Therapeutics 01/2021 - 10/2006
1	Immunotherapy 01/2022